Redsense: Clamp nears market lauch as summative evaluation review completed

Redsense Medical announces that the summative evaluation review for the Clamp has been successfully completed by the independent test house. This marks a key milestone in the product's journey to market, confirming its compliance with the highest standards of performance, safety, and reliability.

With the evaluation phase now concluded, the Clamp is in its final pre-launch stage. Remaining steps now include the finalization and release of internal design documentation, instructions for use, labelling, and completing the certificate of conformity, including CE marking. The Clamp will be launched initially through active distributors in both the UK and Canada, with first sales expected by the end of this month.

"We're excited that we'll soon be able to start selling the Clamp. We plan to join our distributors on a round of visits to introduce the product directly to key partners. We look forward to communicating back to the market and our investors once the Clamp is fully ready for sale. We're hopeful to make our first sales quickly, as we've been actively preparing with our distributors in anticipation of this launch," says Sebastien Bollue, CEO of Redsense Medical AB.

This information is information that Redsense Medical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Market Act. The information was submitted for publication, through the agency of the contact person specified above, on May 7, 2025, at 09:38 CET.